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ABSTRACT 
 
A comprehensive literature search was conducted to identify all case-control studies in-
vestigating the association between GRIN1 G1001C polymorphism and schizophrenia suscep-
tibility (MIM: 138249; dbSNP: rs 11146020). A total of 6 eligible studies (including 1639 
schizophrenia cases and 1489 controls) were identified for the meta-analysis. Including all 
studies, there was significant heterogeneity between studies. In overall the GC (OR=1.00, 
95 % CI: 0.0.85-1.19) and CC (OR=1.09, 95 % CI: 0.67-1.79) genotypes were not associated 
with schizophrenia risk compared with the GG genotype. In one study patients were diag-
nosed using DSM-IIIR criteria and in another study the genotypic frequencies of control sub-
jects showed significant deviation from the expected frequencies according to the Hardy-
Weinberg equilibrium. After excluding these studies from the meta-analysis, the heterogene-
ity between studies dramatically decreased. Statistical analysis showed that the GC genotype 
compared with the GG genotype significantly increased the risk of schizophrenia (OR=1.85, 
95 % CI: 1.43-2.42, P<0.0001). The CC versus GG genotype significantly increased the 
schizophrenia risk (OR=2.46, 95% CI: 1.17-6.84, P=0.017). There was significant linear trend 
for presence of 0, 1, and 2 of the C allele and risk of schizophrenia (χ2=25.45, P<0.0001). In 
conclusion, the C variant allele may be associated with an increased risk for developing 
schizophrenia.  
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INTRODUCTION 
 
Among many theories proposed for the 
pathogenesis of schizophrenia, dysfunction 
of the glutamate neurotransmitter system 
attracts much attention (Belsham, 2001). 
Several genes that encode N-methyl-D-
aspartate (NMDA) receptors have been 
cloned, including GRIN1 (MIM: 138249) 
(Brett et al., 1994). Decreased expression of 
GRIN1 has been observed in various brain 
regions in schizophrenic patients (Sokolov, 
1998; Gao et al., 2000; Ibrahim et al., 
2000). Also, reduced expression of Grin1 
leads to behavioral abnormalities in mice 
that are similar to those observed in phar-
macologically induced models of schizo-
phrenia (Mohn et al., 1999).  
 
In literature, several single nucleotide 
polymorphisms were described in GRIN1, 
including G1001C in the promoter region 
(dbSNP: rs 11146020). Previous studies 
investigating the association between this 
polymorphism and risk of schizophrenia 
have provided inconsistent results (Begni et 
al., 2003; Martucci et al., 2003; Qin et al., 
2005; Zhao et al., 2006; Georgi et al., 2007; 
Li et al., 2008; Galehdari et al., 2009; 
Betcheva et al., 2009). The lack of concor-
dance across the studies might have been 
due to individual studies, that have no suf-
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ficient statistical power to detect the effect 
of polymorphism on the schizophrenia sus-
ceptibility, differences between the study 
populations, or differences in the study de-
sign. Meta-analysis can summarize results 
from different studies by producing a single 
estimate of the major effect with enhanced 
precision. One of the major advantages of a 
meta-analysis is that it decreases the prob-
ability that random error will produce false-
negative or false-positive association. 
Therefore, a meta-analysis could assist in 
estimating population-wide effects of 
polymorphisms in human disease and pro-
vide more reliable results than a single 
study. No meta-analysis investigating the 
association between GRIN1 G1001C poly-
morphism and susceptibility to schizophre-
nia has been conducted to date. Therefore 
the present study was done. 
 
MATERIALS AND METHODS 
 
Literature search strategy 
Eligible studies were identified by 
searching the MEDLINE (National Library 
of Medicine, Washington, DC, USA), Sco-
pus, EBSCOhost Research Databases, Pro-
Quest, EMBASE, Directory of Open Ac-
cess Journals (DOAJ) and CAB Abstract 
for relevant reports before September 2009. 
Search terms were different combinations 
of “GRIN1”, “schizophrenia”, and “poly-
merphism”. The following criteria were 
used for the literature selection for the 
meta-analysis: (1) The article should be 
published in English; (2) Only case-control 
studies were considered; (3) The associa-
tion study of G1001C polymorphism and 
schizophrenia risk were considered; (4) 
Only published articles in scientific journals 
were considered, therefore meeting ab-
stracts and unpublished reports were not 
considered. 
 
Data extraction 
I extracted the following information 
from each article: author(s), year of publi-
cation, country of origin, criteria used for 
schizophrenia diagnosis, ethnicity, genotyp-
ing information, and number of cases and 
controls. For studies including subjects of 
different populations, data were extracted 
separately.  
 
Reports of Martucci et al. (2003) and 
Betcheva et al. (2009) were not included in 
the study because raw data were not men-
tion in these articles. One study was not in-
cluded in the analysis because the article 
was published in Chinese language (Li et 
al., 2008). The report of Galehdari et al. 
(2009) that included two different case-
control groups was considered as two stud-
ies, in the meta-analysis. The application of 
these criteria yielded 6 case-control studies 
eligible for meta-analysis (Begni et al., 
2003; Qin et al., 2005; Zhao et al., 2006; 
Georgi et al., 2007; Galehdari et al., 2009).  
 
Statistical analysis 
Pearson’s χ2 test was used to determine 
whether the observed frequencies of geno-
types for control group in each study con-
formed to the Hardy-Weinberg equilibrium. 
The heterogeneity between studies was de-
termined using Cochran’s Q test, and the 
heterogeneity was considered significant for 
P<0.05. The strength of the associations 
between schizophrenia and the G1001C 
polymorphism was estimated by odds ratios 
(ORs) and 95 % confidence interval (CI). I 
estimated the risk of the genotypes GC and 
CC in comparison with the putative low 
risk GG genotype. A random effects model 
(DerSimonian and Laird, 1986) was se-
lected to pool data if there is significant 
heterogeneity, otherwise, the Mantel-
Haenszel fixed effects model was used 
(Mantel and Haenszel, 1959). Also the lin-
ear trend for presence of 0, 1, and 2 high 
risk variant allele (C allele) and risk of 
schizophrenia was performed using χ2 test. 
The P-value less than 0.05 considered sta-
tistically significant. 
 
RESULTS AND DISCUSSION 
 
For the present meta-analysis 5 pub-
lished articles dealing with 6 case-control 
studies were selected (Begni et al., 2003; 
Qin et al., 2005; Zhao et al., 2006; Georgi 
EXCLI Journal 2010;9:11-16  ISSN 1611-2156 
Received: October 20, 2009, accepted: January 24, 2010, published: January 26, 2010 
 
13 
et al., 2007; Galehdari et al., 2009). From 
these studies, 4, and 2 studies were carried 
out in Asian and European countries, re-
spectively. Data were available from 6 stud-
ies, including 1639 patients and 1489 con-
trol subjects (Table 1). The numbers in the 
case-control studies varied considerably 
(range 178 to 1373 individuals). In all of 
the studies, patients were diagnosed using 
DSM-IV criteria except one study that used 
DSM-IIIR criteria (Zhao et al. 2006). In all 
studies the distribution of genotypes in the 
control group was consisted with Hardy-
Weinberg equilibrium (Begni et al., 2003; 
Qin et al., 2005; Zhao et al., 2006; Georgi 
et al., 2007), except for one study 
(Galehdari et al., 2009). There was signifi-
cant difference in frequency of the variant 
C allele between Asian and European popu-
lations. Overall, the prevalence of the C al-
lele among Asian controls was significantly 
higher than that in Caucasians (Table 1). 
 
Including all studies, there was signifi-
cant heterogeneity between the studies (Ta-
ble 2). In overall, the GC genotype was not 
associated with schizophrenia risk com-
pared with the GG genotype (OR=1.00, 
95 % CI: 0.85-1.19). The same result ob-
tained in comparison of CC versus GG 
genotypes (OR=1.09, 95 % CI: 0.67-1.79).  
 
In order to find the source of heteroge-
neity between the studies, we excluded one 
case-control study from the Galehdari et al. 
(2009) report, because its control group was 
not at Hardy-Weinberg equilibrium 
(χ2=39.50, df=1, P<0.0001). However, the 
heterogeneity did not decrease significantly. 
In the study of Zhao et al. (2006) patients 
were diagnosed using DSM-IIIR criteria, 
whereas, in the other studies DSM-IV crite-
ria was used. After excluding these studies 
from the analysis, the heterogeneity be-
tween the studies dramatically decreased 
(Table 2). Statistical analysis showed that 
the GC genotype compared with the GG 
genotype significantly increased the risk of 
schizophrenia (OR=1.85, 95 % CI: 1.43-
2.42, P<0.0001). The CC versus GG geno-
types significantly increased the schizo-
phrenia risk (OR=2.46, 95 % CI: 1.17-6.84, 
P=0.017). There was significant linear trend 
for presence of 0, 1, and 2 of the C allele 
and risk of schizophrenia (χ2=25.45, 
P<0.0001). 
 
 
Table 1: Studies included in the meta-analysis 
   Control   Case 
Study (year) Place ethnicity GG GC CC C al-
lele 
χ2 
HWE** 
 
 GG GC CC 
Begni et al., 2003 Italy Caucasians 121 23 1 0.0862 0.01  99 36 4 
Qin et al., 2005 China Asians 100 35 5 0.1607 0.77  156 92 5 
Zhao et al., 2006 China Asians 412 244 25 0.2158 2.31  505 174 13 
Georgi et al., 2007 Germany Caucasians 279 42 2 0.0712 0.11  287 64 4 
Galehdari et al., 
2009 
Iran Mixed 28 83 0 0.3738 39.50***  22 84 5 
Galehdari et al., 
2009 
Iran Mixed 53 35 1 0.2078 3.32  24 56 9 
Note: * Criteria used for schizophrenia diagnosis 
** χ2 for testing Hardy-Weinberg equilibrium 
*** P<0.05 
 
EXCLI Journal 2010;9:11-16  ISSN 1611-2156 
Received: October 20, 2009, accepted: January 24, 2010, published: January 26, 2010 
 
14 
Table 2: Summary of meta-analysis of case-control studies examining GRIN1 G1001C polymorphism and 
schizophrenia risk 
  GC vs GG    CC vs GG   
Study df Q statistic OR 95 % CI  Q statistic OR 95 % CI 
All of studies 5 48.96* 1.00 0.85-1.19  17.73* 1.09 0.67-1.79 
All after excluded Galehdari 
2009 study 
4 48.35* 0.99 0.83-1.17  15.85* 0.95 0.57-1.59 
All of studies after excluding  
2 studies 
3 5.14 1.85 1.43-2.42  8.23 2.46 1.17-6.94 
Note: * There is heterogeneity between studies P<0.05. 
 
 
We know that schizophrenia is a multi-
factorial trait with multiple genetic and en-
vironmental factors that contribute to the 
risk of disorder. In pathogenesis of such 
traits the influence of genetic and environ-
mental factors and also their interactions 
may be different between ethnic groups. 
Several meta-analyses indicated that some 
genetic polymorphisms might be associated 
with altered risk of some types of cancers in 
some ethnicity (Hu et al., 2005; Kiyohara et 
al., 2006; Saadat, 2006; Saadat and Ansari-
Lari, 2009). Based on the present study the 
relationship between this genetic variation 
and schizophrenia risk among different eth-
nic groups is an open question.  
 
Because the authors of the original arti-
cles used in the present meta-analysis did 
not mention clearly whether they had used 
hospital based and/or population based con-
trols or other risk factors for schizophrenia, 
stratification of the studies is impossible. It 
is strongly recommended that in future 
studies, the investigators considering the 
“STrengthening the REporting of Genetic 
Association studies (STREGA)” statement 
(Little et al., 2009). It may be concluded 
that the relationship between the GRIN1 
genotypic variation and susceptibility to 
schizophrenia is still an open question. In 
this field further larger case-control studies 
with multi-ethnic population are required. 
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